Lupin: Unit Gets FDA OK To Sell Generic Osteoarthritis Drug
January 14, 2011 at 05:01 AM EST
BANGALORE -(Dow Jones)- Lupin Ltd. (500257.BY) Friday said its U.S unit has received final approval from the U.S. Food and Drug Administration to sell its generic version of nabumetone tablets--in 500 milligram and 750 mg strengths--used for the treatment of osteoarthritis and rheumatoid arthritis.
